Purified granulocytes in extracorporeal cell therapy: A multifaceted approach to combat sepsis-induced immunoparalysis.
Gerd KlinkmannSophie BrabandtMarlene MöllerThomas WildBenjamin HeskampJens-Christian ScheweMartin SauerJens AltrichterSteffen MitznerPublished in: The International journal of artificial organs (2024)
Purified GC remain functional after 72 h of storage and additional 24 h in the circulating treatment model. Cytokine secretion patterns revealed a significant increase, especially between 10 and 24 h of treatment. Extending treatment time holds promise for enhancing immune response against sepsis-induced immunoparalysis. These findings provide valuable insights for optimizing immune-targeted therapeutic interventions.